Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
Isaac AlemanJavier Castillo VelazquezSloan W RushPedro Luis GomezPublished in: The British journal of ophthalmology (2019)
This RCT demonstrated better final visual outcomes, shorter operating times and less vitreous haemorrhage recurrences in the postoperative period when subjects received IVZ compared to IVB prior to PPV for the treatment of PDR-related complications.